Local biopharmaceutical company strikes deal with global player
San Antonio-based Evestra Inc. has struck a deal with a global pharmaceutical company that could open a world of new business opportunities. It ’s entered into a strategic development, licensing and commercialization agreement with Glenmark Pharmaceuticals to develop and market a generic version of Merck& Co. Inc. ’s NuvaRing birth control product.
Evestra — an emerging player in biopharmaceutical research and development with a therapeutic focus on women’s health care — plans to develop…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: W. Scott Bailey Source Type: news